Methylene blue is a synthetic compound first made in a German dye factory in 1876. Its scientific name is methylthioninium chloride, and its molecular formula is C16H18ClN3S. It looks like a dark, almost black-purple crystalline powder in solid form and turns deep blue the moment it dissolves in water. That deep blue is not a coincidence — it is the visual signature of a molecule that has been useful to chemists, biologists, and physicians for a century and a half.
The short answer
Methylene blue is a small organic molecule with a strong, stable blue color and a reversible chemical property called redox cycling. It was the first fully synthetic drug ever used in medicine, the first compound used to selectively stain bacteria under a microscope, and the parent molecule of an entire family of dyes and pharmaceuticals. Today it is recognized by the World Health Organization as an essential medicine for specific medical uses, and it is the subject of active research in cell biology, neuroscience, and infectious disease.
Where it came from
In 1876, a German chemist named Heinrich Caro working at the BASF dye works synthesized methylene blue for use in the textile industry. The dye was a commercial success — silk and cotton took it readily, and the blue did not wash out — but it quickly attracted attention beyond textiles. By the early 1880s, the bacteriologist Robert Koch and his colleagues had discovered that the dye selectively stained certain bacteria, making them visible under a microscope for the first time. That single use case opened up modern microbiology.
A few years later, Paul Ehrlich — the scientist who coined the term "magic bullet" for targeted medicine — used methylene blue to treat malaria. It worked. That made methylene blue the first fully synthetic compound ever used as a drug in human medicine, the start of the modern pharmaceutical industry. Every synthetic drug that exists today traces its lineage, in some philosophical sense, back to that decision.
The chemistry, plainly
Methylene blue is a phenothiazine derivative — a flat, three-ring molecule with nitrogen and sulfur atoms in the central ring. The blue color comes from the way those rings absorb light: they soak up red and yellow wavelengths and reflect the blue back to your eye.
The most interesting chemical property is its reversible redox cycle. When methylene blue gains an electron, it becomes a colorless form called leucomethylene blue. When it loses that electron — as soon as it meets oxygen, for example — it turns blue again. This switch happens easily and can repeat indefinitely. It is the basis of the classic "blue bottle" chemistry-class demonstration, and it is the property that makes the molecule biologically interesting: anything that can pick up and drop off electrons reliably can participate in the electron-transfer chemistry that runs through every living cell.
Genuine methylene blue cycles between blue and colorless under reducing conditions and returns to blue on exposure to air. This is one informal check that a sample is the real compound and not an industrial dye sold under the same name. It is not a test of purity or concentration — only an ISO/IEC 17025 accredited lab COA can confirm those.
How methylene blue is used in medicine
Methylene blue has a small number of well-established medical uses, prescribed and administered in clinical settings. It is the first-line treatment for methemoglobinemia, a condition in which red blood cells lose their ability to carry oxygen — methylene blue restores their function within minutes. It is used during certain surgeries as a visual contrast agent so surgeons can see lymph nodes and tissue structures. It is given for cyanide and ifosfamide-induced toxicity. And in some jurisdictions it is part of the protocol for vasoplegic syndrome during cardiac surgery.
These uses involve specific doses, specific routes of administration, and physician supervision. They are the reason methylene blue appears on the World Health Organization's Model List of Essential Medicines and the reason pharmacopeial standards (USP, BP, EP) for the compound are so well established.
What researchers are studying now
Recent attention to methylene blue outside the hospital setting is driven by a different question: what does this molecule do at the cellular level, and where else might its redox chemistry be useful? Active areas of scientific research include:
- Mitochondrial function and cellular energetics. Methylene blue can act as an alternative electron carrier in the mitochondrial electron transport chain — the system inside every cell that produces ATP, the molecule cells use for energy. Researchers are studying whether and how this matters in cells with damaged or stressed mitochondria.
- Neuroscience and cognition. Animal and early human studies have explored methylene blue's effects on memory tasks, neural metabolism, and neurodegenerative protein aggregation. This research is preliminary; conclusions for human consumer use have not been established.
- Antimicrobial and antiparasitic activity. Building on the original 1890s antimalarial work, methylene blue is being re-examined in combination protocols for malaria and other parasitic infections.
- Photodynamic therapy. Methylene blue can be activated by specific wavelengths of light to produce reactive oxygen species, a property being studied for targeted use in dentistry and dermatology.
It is important to be precise about what this means. "Researchers are studying" is not the same as "science has proven." A compound being investigated in laboratory and early clinical research is a compound where questions are being asked, not a compound where therapeutic conclusions have been reached for general consumer use. Anyone who tells you methylene blue definitively does X for the average person is overstating what the research currently shows.
Why methylene blue is in the conversation right now
For most of the twentieth century, methylene blue was a quiet workhorse — a hospital drug, a histology stain, an aquarium treatment. In the past few years it has moved into public conversation through podcasts, biohacking forums, and long-form interviews with researchers and physicians who study cellular metabolism. That attention has driven a wave of interest from people curious about a compound that is, by historical standards, unusually well characterized and unusually old.
This is a reasonable reason to want to understand what methylene blue is. It is also a reason to be careful: rising interest tends to outpace rising quality control across suppliers, and a compound that is easy to manufacture cheaply is a compound that easily reaches consumers as a low-quality version of itself. The rest of this buyer's guide is designed to help you tell the difference.
Quality and safety: the part that matters
Three things are worth knowing before you go further.
Purity varies enormously by source. The same compound can arrive at your door from a pharmaceutical-grade Canadian manufacturer or from a textile-dye supplier in another country. They look identical in the bottle. The only way to tell which is which is the certificate of analysis (COA), which is the focus of guide #3 in this series. Every Nutrivance Laboratories batch is tested by an ISO/IEC 17025 accredited independent lab, and the COA is matched to your specific bottle.
It is light- and time-sensitive. Dissolved methylene blue degrades when exposed to light. Quality suppliers use opaque packaging and print best-by dates. Nutrivance ships its solutions in matte-black bottles that block light entirely, with the batch number and best-by printed on every label.
There are real drug interactions to take seriously. Methylene blue is a monoamine oxidase inhibitor at clinical doses. In combination with serotonergic medications — SSRIs, SNRIs, MAOIs, certain pain medications — it can cause serotonin syndrome, a serious and sometimes life-threatening reaction. It can also cause hemolysis (red blood cell breakdown) in people with G6PD deficiency, an inherited condition more common in some populations than others. Anyone considering methylene blue should consult a qualified healthcare provider, especially if they are on any of the medications above or have a relevant family history.
Shop the line
Made in Canada · Batch-tested · COA per bottle
Nutrivance Laboratories methylene blue, available in 1% and 2% solutions and 20 mg pressed tablets. Every batch tested by an ISO/IEC 17025 accredited independent lab.
Frequently asked questions
Is methylene blue a drug? Yes, in the regulated sense — it appears on the WHO Essential Medicines list and on national pharmacopeias as methylthioninium chloride. It is approved for specific medical uses administered by clinicians. Products sold for general use outside those indications are not approved drugs.
Why is it blue? The phenothiazine ring system absorbs red and yellow wavelengths of light and reflects blue. The same chemistry is also responsible for the molecule's redox behavior.
Is it safe to take? That question does not have a single answer — it depends on the dose, the form, the person's health and medications, and the indication. Methylene blue interacts with several common medication classes (notably serotonergic drugs) and is unsafe for people with G6PD deficiency. Anyone considering use should consult a qualified healthcare provider.
How do I know what I'm buying is real methylene blue? The reversible blue-to-colorless redox cycle can suggest authenticity, but only a third-party certificate of analysis confirms identity, purity, and the absence of heavy-metal contamination. Always ask for the COA — and if a supplier cannot produce one, do not buy from them.